<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font17 { font-size : 17; } .font20 { font-size : 20; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">and </span>
   <span class="font30">the </span>
   <span class="font20">reinfection </span>
   <span class="font17">HCV </span>
   <span class="font17">studies </span>
   <span class="font15">with </span>
   <span class="font15">for </span>
   <span class="font14">from </span>
   <span class="font14">PWID </span>
   <span class="font14">among </span>
   <span class="font14">{background </span>
   <span class="font13">rates </span>
   <span class="font13">treatment </span>
   <span class="font13">hepatitis </span>
   <span class="font13">that </span>
   <span class="font13">not </span>
   <span class="font12">The </span>
   <span class="font12">margin </span>
   <span class="font12">study </span>
   <span class="font12">who </span>
   <span class="font12">virus </span>
   <span class="font12">were </span>
   <span class="font12">{border-style </span>
   <span class="font12">[]. </span>
   <span class="font12">people </span>
   <span class="font12">px;} </span>
   <span class="font12">#ffffff;} </span>
   <span class="font12">relapse </span>
   <span class="font12">data </span>
   <span class="font12">middle-income </span>
   <span class="font12">per </span>
   <span class="font12">review </span>
   <span class="font11">are </span>
   <span class="font11">included </span>
   <span class="font11">inject </span>
   <span class="font11">after </span>
   <span class="font11">lower </span>
   <span class="font11">rate </span>
   <span class="font11">this </span>
   <span class="font11">cases </span>
   <span class="font11">countries </span>
   <span class="font11">these </span>
   <span class="font11">used </span>
   <span class="font11">DAA </span>
   <span class="font11">have </span>
   <span class="font11">use </span>
   <span class="font11">high-income </span>
   <span class="font11">may </span>
   <span class="font11">testing </span>
   <span class="font11">weeks </span>
   <span class="font11">This </span>
   <span class="font11">antiviral </span>
   <span class="font11">conducted </span>
   <span class="font11">drugs </span>
   <span class="font11">follow-up </span>
   <span class="font11">infection </span>
   <span class="font11">only </span>
   <span class="font11">research </span>
   <span class="font11">systematic </span>
   <span class="font11">was </span>
   <span class="font11">background </span>
   <span class="font11">between </span>
   <span class="font11">countries. </span>
   <span class="font11">deep </span>
   <span class="font11">different </span>
   <span class="font11">health </span>
   <span class="font11">px; </span>
   <span class="font11">results </span>
   <span class="font11">search </span>
   <span class="font11">sequencing </span>
   <span class="font11">viral </span>
   <span class="font11">{font-family </span>
   <span class="font10">Hepatitis </span>
   <span class="font10">Table </span>
   <span class="font10">[,]. </span>
   <span class="font10">al., </span>
   <span class="font10">available </span>
   <span class="font10">can </span>
   <span class="font10">clinical </span>
   <span class="font10">did </span>
   <span class="font10">font-size </span>
   <span class="font10">gene </span>
   <span class="font10">genotyping </span>
   <span class="font10">including </span>
   <span class="font10">low </span>
   <span class="font10">low-income </span>
   <span class="font10">our </span>
   <span class="font10">patients </span>
   <span class="font10">primary </span>
   <span class="font10">ranged </span>
   <span class="font10">regimens </span>
   <span class="font10">Infect. </span>
   <span class="font10">RNA </span>
   <span class="font10">While </span>
   <span class="font10">also </span>
   <span class="font10">country </span>
   <span class="font10">double; </span>
   <span class="font10">elimination </span>
   <span class="font10">following </span>
   <span class="font10">high-risk </span>
   <span class="font10">information </span>
   <span class="font10">meta-analysis </span>
   <span class="font10">methods </span>
   <span class="font10">one </span>
   <span class="font10">participants </span>
   <span class="font10">resource-limited </span>
   <span class="font10">risk </span>
   <span class="font10">than </span>
   <span class="font10">upper </span>
   <span class="font10">which </span>
   <span class="font10">Despite </span>
   <span class="font10">LMICs </span>
   <span class="font10">Reinfection </span>
   <span class="font10">SVR </span>
   <span class="font10">Viral </span>
   <span class="font10">access </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">chronic </span>
   <span class="font10">clearance </span>
   <span class="font10">compared </span>
   <span class="font10">countries, </span>
   <span class="font10">delineated </span>
   <span class="font10">direct-acting </span>
   <span class="font10">factors </span>
   <span class="font10">found </span>
   <span class="font10">had </span>
   <span class="font10">highly </span>
   <span class="font10">limited </span>
   <span class="font10">more </span>
   <span class="font10">number </span>
   <span class="font10">prevalence </span>
   <span class="font10">published </span>
   <span class="font10">recurrence </span>
   <span class="font10">reinfection, </span>
   <span class="font10">reported </span>
   <span class="font10">solid; </span>
   <span class="font10">strain </span>
   <span class="font10">time </span>
   <span class="font10">using </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">$,) </span>
   <span class="font10">(e.g., </span>
   <span class="font10">Cohort </span>
   <span class="font10">Health </span>
   <span class="font10">LMICs. </span>
   <span class="font10">Male </span>
   <span class="font10">OST </span>
   <span class="font10">Our </span>
   <span class="font10">People </span>
   <span class="font10">Study </span>
   <span class="font10">These </span>
   <span class="font10">about </span>
   <span class="font10">additional </span>
   <span class="font10">all </span>
   <span class="font10">associated </span>
   <span class="font10">bold </span>
   <span class="font10">care </span>
   <span class="font10">courier; </span>
   <span class="font10">distinguish </span>
   <span class="font10">drug </span>
   <span class="font10">em; </span>
   <span class="font10">further </span>
   <span class="font10">genotype </span>
   <span class="font10">global </span>
   <span class="font10">has </span>
   <span class="font10">high </span>
   <span class="font10">highest </span>
   <span class="font10">income </span>
   <span class="font10">lack </span>
   <span class="font10">least </span>
   <span class="font10">measuring </span>
   <span class="font10">method </span>
   <span class="font10">most </span>
   <span class="font10">multiple </span>
   <span class="font10">need </span>
   <span class="font10">observed </span>
   <span class="font10">pt;} </span>
   <span class="font10">recent </span>
   <span class="font10">review, </span>
   <span class="font10">role </span>
   <span class="font10">sample </span>
   <span class="font10">sequencing, </span>
   <span class="font10">settings. </span>
   <span class="font10">should </span>
   <span class="font10">significant </span>
   <span class="font10">strains </span>
   <span class="font10">strategy </span>
   <span class="font10">sustained </span>
   <span class="font10">therapy </span>
   <span class="font10">they </span>
   <span class="font10">those </span>
   <span class="font10">three </span>
   <span class="font10">virologic </span>
   <span class="font10">when </span>
  </p>
 </body>
</html>
